mlsanityData to 14 Oct 2026

Interpretable Machine Learning for Antepartum Prediction of Pregnancy-Associated Thrombotic Microangiopathy Using Routine Longitudinal Laboratory Data

arXiv 2605.13786 ↗First posted 13 May 2026cs.LGcited by 0

Not on the map. Why?

Abstract (arXiv)

Background: Pregnancy-associated thrombotic microangiopathy (P-TMA) is rare but life-threatening. Early risk prediction before overt clinical presentation remains challenging, as the associated laboratory abnormalities are subtle, multidimensional, and frequently masked by common physiological changes such as gestational thrombocytopenia and pregnancy-related proteinuria, thus overlapping heavily with benign obstetric and renal conditions. This complexity is poorly captured by univariate or rule-based approaches; however, it is addressable by machine learning, which can extract latent, time-dependent risk signatures from longitudinal clinical tests. Methods: This retrospective study included 300 pregnancies comprising 142 P-TMA cases and 158 controls. After exclusion of identifiers and non-informative variables, 146 longitudinal laboratory predictors were retained. Participants were divided into a training cohort (80%) and a held-out test cohort (20%) using stratified sampling. Five algorithms were evaluated: logistic regression, support vector machine with radial basis function kernel, random forest, extra trees, and gradient boosting. The final model was selected by mean cross-validated AUROC, refitted on the full training cohort, and evaluated once in the held-out test cohort. Interpretability analyses examined global feature importance and distributional patterns of leading predictors. Results: Gradient boosting was prespecified by cross-validation in the training cohort. The model achieved an AUROC of 0.872 (95% CI: 0.769-0.952) and an AUPRC of 0.883 (95% CI: 0.780-0.959) in a held-out test cohort, with sensitivity of 0.750 and specificity of 0.812. Conclusions: Longitudinal clinical laboratory tests obtained during routine care contained informative and clinically plausible signals for P-TMA risk. Notably, cystatin C at week 6 showed promise as an early monitoring indicator.

Key facts. No citing papers in the map yet (data through 14 Oct 2026). Builds on 8 of its 48 references that are in the map. First posted on arXiv 13 May 2026.

Builds on

8 of 48 references.

References · 8

  1. 2021Deep Neural Networks and Tabular Data: A Surveycited by 491
  2. 2019A Survey on Explainable Artificial Intelligence (XAI): Towards Medical XAIcited by 404
  3. 2018Confounding variables can degrade generalization performance of radiological deep learning modelscited by 379
  4. 2019What Clinicians Want: Contextualizing Explainable Machine Learning for Clinical End Usecited by 135
  5. 2018A Review of Challenges and Opportunities in Machine Learning for Healthcited by 68
  6. 2020A Review of Deep Learning Methods for Irregularly Sampled Medical Time Series Datacited by 31
  7. 2018Learning Structure and Strength of CNN Filters for Small Sample Size Trainingcited by 8
  8. 2024Survival modeling using deep learning, machine learning and statistical methods: A comparative analysis for predicting mortality after hospital admissioncited by 1

Built on by

Not cited yet.